Metastatic breast cancer (MBC) is typically an incurable disease with high mortality rates;
thus, early identification of metastatic features and disease recurrence through precise …

Liquid biopsy based on the analysis of circulating tumor cells (CTCs) has emerged as an
important field of research. Molecular characterization of CTCs can provide insights into …

The detection of circulating tumor cells (CTCs) in the peripheral blood of metastatic breast
cancer (MBC) patients is an independent marker of prognosis. This large prospective …

At present, the majority of patients with breast cancer are diagnosed at early stages of
disease development. However, a considerable number of such cases develop secondary …

Metastasis describes the process of migration of a frequently clinically occult circulating
tumor cell (CTC) from the primary lesion to a new location and the subsequent formation of …

Molecular characterization of circulating tumor cells (CTC) from blood is technically
challenging because cells are rare and difficult to isolate. We developed a novel approach …

The largest difficulty one faces in the development of technology for detection of circulating
tumor cells (CTCs) is whether or not tumor cells are present in the blood and at what …

Background. Evidence is accumulating that circulating tumor cells (CTC) out of peripheral
blood can serve as prognostic marker not only in metastatic but also in early breast cancer …

Background: Circulating Tumor Cells (CTCs) detection in peripheral blood of epithelial
cancer patients is an indicator of the presence of primary tumors and metastasis. The CTC …

Background: The enumeration of circulating tumour cells (CTCs) with the EpCAM-based
CellSearch system has prognostic significance in patients with metastatic breast cancer …